IBB ETF holdings (NASDAQ) - Page 2 | MetaTrader

Open full chart

Overview All holdings Heatmap

Top holdings Market Value Shares Weight %

IONS Ionis Pharmaceuticals, Inc. 90.525 M 1.206 M 1.114%

MEDP Medpace Holdings, Inc. 81.595 M 169.922 K 1.005%

MDGL Madrigal Pharmaceuticals, Inc. 81.316 M 155.341 K 1.001%

EXEL Exelixis, Inc. 80.261 M 1.871 M 0.988%

BMRN BioMarin Pharmaceutical, Inc. 79.783 M 1.412 M 0.982%

Ascendis Pharma A/S 77.756 M 339.948 K 0.957%

PRAX Praxis Precision Medicines, Inc. 62.858 M 195.097 K 0.774%

CRL Charles River Laboratories International, Inc. 62.473 M 362.165 K 0.769%

ARWR Arrowhead Pharmaceuticals, Inc. 61.143 M 975.175 K 0.753%

PCVX Vaxcyte, Inc. 60.765 M 1.046 M 0.748%

TECH Bio-Techne Corp. 60.201 M 1.152 M 0.741%

CYTK Cytokinetics, Inc. 59.119 M 896.972 K 0.728%

HALO Halozyme Therapeutics, Inc. 56.131 M 868.502 K 0.691%

AXSM Axsome Therapeutics, Inc. 53.932 M 319.088 K 0.664%

BNTX BioNTech SE 53.284 M 599.506 K 0.656%

KRYS Krystal Biotech, Inc. 48.814 M 188.966 K 0.601%

PTGX Protagonist Therapeutics, Inc. 47.119 M 447.047 K 0.580%

RGEN Repligen Corp. 46.762 M 396.896 K 0.576%

KYMR Kymera Therapeutics, Inc. 43.426 M 521.385 K 0.535%

ALKS Alkermes plc 43.021 M 1.217 M 0.530%

1
2
3
4
5
6
7
8
...
13

News

Global Markets: Fundamentals Have The Floor

Healthcare Investing: Finding Growth Beyond Pharmaceuticals

SBIO: Biotech Breakthrough Opportunities Screened For Cash Burn (NYSEARCA:SBIO)

The chip pullback is ushering in a bumpy market. These sectors are the best bets now, according to Morgan Stanley.

The Week The AI Trade Broke, And Why The Data Says 'Rotation,' Not 'Recession'

America At 250: Built On Reinvention, Powered By Innovation

Biotech Is The Rate Cut Trade In Disguise

Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It (NYSEARCA:XLV)

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Weekly Market Pulse: It's An AI Stock World

Stock Market Week Ahead: Rotating, For Now, Away From The AI Boom

Zacks Investment Ideas feature highlights: IBB, Novartis, Pfizer and Eli Lilly's